Lea Kuppers-Tiedt
Overview
Explore the profile of Lea Kuppers-Tiedt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuppers-Tiedt L, Steiner T
Front Neurol Neurosci
. 2015 Nov;
37:27-34.
PMID: 26588581
Outcome of intracerebral hemorrhage (ICH) is still poor and siginificantly influenced by complications during the acute phase, so optimized neurocritical care is crucial. Vital parameters, neurological status and laboratory values...
2.
Michalski D, Weise C, Hobohm C, Kuppers-Tiedt L, Pelz J, Schneider D, et al.
Exp Transl Stroke Med
. 2012 Apr;
4(1):7.
PMID: 22510241
Background: Since several neuroprotectives failed to reproduce promising preclinical results under clinical conditions, efforts emerged to implement clinically relevant endpoints in animal stroke studies. Thereby, insufficient attention was given on...
3.
Hobohm C, Laignel F, Kacza J, Kuppers-Tiedt L, Heindl M, Schneider D, et al.
Brain Res
. 2011 Sep;
1417:115-26.
PMID: 21914554
Acute focal cerebral ischemia and consecutive energy failure are accompanied by neuronal death in regions with impaired cerebral blood flow. Several translational attempts of potential neuroprotective agents have failed, hence...
4.
Kuppers-Tiedt L, Manaenko A, Michalski D, Guenther A, Hobohm C, Wagner A, et al.
Acta Neurochir Suppl
. 2011 Jul;
111:167-72.
PMID: 21725750
Introduction: The only causal therapy in ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (rtPA), but it is feasible only for few patients, and new therapies are needed. This...
5.
Michalski D, Kuppers-Tiedt L, Weise C, Laignel F, Hartig W, Raviolo M, et al.
Brain Res
. 2009 Sep;
1303:161-8.
PMID: 19766603
The combination of hyperbaric oxygen therapy (HBO) and recombinant tissue-plasminogen activator (tPA) is of interest in the treatment of acute ischemic stroke with a view to combine positive effects of...
6.
Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, et al.
Stroke
. 2009 Sep;
40(12):e657-65.
PMID: 19762706
Background And Purpose: We sought to study the effectiveness and safety of endovascular cooling to maintain prophylactic normothermia in comparison with standardized, stepwise, escalating fever management to reduce fever burden...
7.
Voigt C, Forschler A, Jaeger M, Meixensberger J, Kuppers-Tiedt L, Schuhmann M
Acta Neurochir Suppl
. 2009 Apr;
102:441-5.
PMID: 19388363
Background: We evaluated the effect of hyperbaric oxygen therapy (HBO) on experimental brain contusions in rats using magnetic resonance imaging (MRI). Materials And Methods: Ten Sprague-Dawley rats were investigated at...
8.
Henninger N, Kuppers-Tiedt L, Sicard K, Gunther A, Schneider D, Schwab S
Exp Neurol
. 2006 Jul;
201(2):316-23.
PMID: 16814772
The potential neuroprotective effects of hyperbaric oxygen (HBO) were tested in an embolic model of focal cerebral ischemia with partially spontaneous reperfusion. Rats (n = 10) were subjected to embolic...
9.
Gunther A, Kuppers-Tiedt L, Schneider P, Kunert I, Berrouschot J, Schneider D, et al.
Eur J Neurosci
. 2005 Jun;
21(11):3189-94.
PMID: 15978027
Permanent middle cerebral artery occlusion (MCAO) causes neurodegeneration and a robust activation of glial cells primarily in sensorimotor brain regions of rats. It has been shown that hyperbaric oxygen (HBO)...